FOURTH REPORT
The Welsh Affairs Committee has agreed to the
following Report:
HEALTH ISSUES IN WALES
Introduction
1. On 1 July responsibility for the management and
funding of the National Health Service in Wales will pass to the
National Assembly of Wales. It is therefore timely for us to report
the findings of a short inquiry we have held into current health
issues in Wales. We received a number of written submissions and
held two sessions of oral evidence. We took evidence from the
NHS Confederation in Wales, and from the University Hospital of
Wales Healthcare NHS Trust on 23 March; and from the Secretary
of State for Wales and Welsh Office representatives on 30 March.
We have also drawn considerably on the Report of the Comptroller
and Auditor General on the NHS (Wales) Summarised Accounts 1997-98.[1]
We make this short Report to the House to inform fellow Members,
and also colleagues in the National Assembly, about some of the
concerns raised in evidence. We are reporting separately on Paediatric
Cardiac Services in Wales, a matter which we consider requires
to be addressed with particular urgency.[2]
Structural change
2. The past year has been a time of major organisational
change for the National Health Service in Wales.[3]
On 1 April 1999, the internal market in healthcare and GP fundholding
were abolished and Local Health Groups were established. Contracting
is being replaced by Long Term Agreements and Health Improvement
Programmes. The number of NHS trusts has been reduced from 26
to 16. The Welsh Health Commons Services Authority has been abolished,
and the Health Promotion Authority has been absorbed into the
Welsh Office. Within the Welsh Office, the management of the Health
Department has been restructured. The NHS Confederation expressed
the understandable hope that, after this period of "managerial
turbulence", they would be left in peace for a few years.[4]
While the National Assembly will, quite properly, wish to make
its mark on the NHS in Wales, we hope that it will see the benefits
of a period of calm after the structural upheaval of the last
year.
NHS financial performance
3. The financial performance of many health authorities
and trusts in Wales continues to be a matter of very serious concern.
The Welsh Office's memorandum showed that by March 1999, the cumulative
deficit had risen to some £54.1 million, with the number
of trusts operating at a deficit increasing to 12.[5]
In his report on the 1997-98 Accounts, the Comptroller and Auditor
General expressed his concern about the size of the forecast deficits
and about the adequacy of the recovery plans in place.[6]
The Secretary of State has announced that a "stocktake"
of the overall financial position and management of the NHS in
Wales will take place in 1999-2000.[7]
This is welcome, but it is not enough just to find out how much
the NHS Wales is in the red: something needs to be done about
it. In our view, the Welsh Office has, over the years, allowed
an unacceptable level of debt to build up. The NHS in Wales has
only been kept going by loans from the Welsh Office to health
authorities. Tackling the increasing financial deficit facing
the NHS in Wales must be a clear priority for the National Assembly,
but we fear that the problem will not be easily solved within
the resources currently available to the Assembly.
Emergency admissions
4. The NHS Confederation drew attention to the significant
increase in emergency admissions to hospitals in Wales over recent
years (a 15% increase between 1996 and 1998), not just in the
winter months but throughout the year.[8]
They welcomed the £11.5 million made available by the Welsh
Office last winter, but argued for such funding to be made on
a recurring basis and at an early stage in the financial year.
They pointed out that 20% of the winter pressure money was passed
to Social Services, to support social care. Welsh Office witnesses
agreed that the resource allocation process should allow the health
service to manage emergency admissions without requiring additional
funds.[9]
As the Secretary of State said, "we need to have good
planning and long-term management which deals with the ups and
downs rather than ... crisis management".[10]
NHS pay awards
5. The NHS Confederation also drew attention to the
impact on the health service of nationally agreed pay awards.[11]
The impact of wage awards in the current year was expected to
be some £80 million, and the impact of other workforce changes
(including junior doctors' hours) a further £7-10 million.
Pay accounts for some 70-75% of a typical trust's expenditure.
The Director of the Welsh Office Health Department assured us
that health authorities would be given an allocation for the current
year which would cover the pay awards in full, though how allocations
were spent was a matter for individual authorities.[12]
We note that staff pay is a key area in which decisions made outside
Wales (and outside the control of the National Assembly) impact
directly on the resources available for patient care in Wales.
We are concerned about the low level of pay of NHS staff, including
technical service staff, and hope that this will be addressed
in the Government's review of the NHS pay system.
Drugs
6. The NHS Confederation emphasised the increasing
cost of the primary care drugs bill, which they suggested would
rise by some £30 million above the £350 million it cost
in 1998-99.[13]
There is an increasing number of effective but very expensive
new drugs, in some cases an alternative to surgery. There are
above average levels of ill health in Wales, but it is also notable
that rates of prescribing are significantly higher in Wales
than in England, even in areas of comparable deprivation.
The message needs to be got across to both patients and doctors
that medication is not necessarily the required outcome of a visit
to the doctor. The Welsh Office plans in future to introduce unified
budgets for health authorities, so that drugs expenditure will
be included within health authorities' cash limited allocations.[14]
This would seem a sensible change, so long as the allocations
are realistic.
7. We are also concerned about the varying availability
of drugs between one area and another. For example, there appears
to be variation in the availability of drugs to treat ovarian
cancer. We welcome the establishment of an all-Wales Forum to
consider the efficacy of new drugs. The new UK-wide National Institute
of Clinical Excellence, and the proposed Commission for Health
Improvement, should also improve equity of access, by providing
clinicians and health authorities with better information.[15]
Health inequalities in Wales
8. We received a submission from North Glamorgan
NHS Trust highlighting inequalities in health in Wales.[16]
The Trust maintains that, while the Government is committed to
redressing inequalities of health, the current funding system
and allocation of resources is having the opposite effect. It
argues for better focussed targeting, for clearer guidance to
health authorities that they must address health inequalities
in their funding allocations to trusts and Local Health Groups,
and for funding to compensate for the diseconomies of small size.
Welsh Office witnesses acknowledged the existence of health inequalities,
though they distinguished between inequalities in health and inequalities
in access to services.[17]
We note that the Welsh Office has not adopted the Health Action
Zone approach, as in England, on the ground the Welsh model is
based on much smaller communities. However, it has established
an expert group to advise on a system for monitoring health inequalities
and to establish targets. Continuing health inequalities in
Wales are a matter of very great concern, and will be a central
challenge for the National Assembly. It is also an area which
is likely to impact on our own work, since we are planning to
conduct an inquiry into social exclusion in Wales after the Summer.
GP services
9. The NHS Confederation reported that some Health
Authorities were experiencing difficulties in recruiting general
practitioners, especially in the Valleys and rural Wales, and
drew attention to the fact that 20% of GPs in Wales will be of
retirement age in the next 5 years.[18]
There is already a crisis in many areas and the situation will
get worse. Efforts are being made to make the vocational training
scheme for GPs more attractive, and to encourage women doctors
to return to work by increasing part-time working and opportunities
for non-principal GPs. A further possibility under consideration
is a salaried service for GPs in disadvantaged areas. Welsh Office
witnesses told us that there was scope at present for the employment
of salaried GPs, though take-up had not been significant.[19]
We accept that a salaried GP service is only part of the solution
to health inequalities in disadvantaged areas, but suggest that
there are lessons to be learned from the success of the dental
initiative. The multi-professional model suggested by Julian Tudor-Hart
in Going for Gold is worth exploring. We urge the National
Assembly to give careful consideration to the recruitment of GPs
in disadvantaged areas, and particularly to the potential for
a salaried service for GPs.
Cross-border funding
10. At our request, the North Wales Health Authority
provided us with a paper on cross-border funding issues.[20]
North Wales residents are referred to English providers in much
greater numbers than in other health authority areas: the population
is not sufficiently large to merit its own specialist services;
services in Chester, Manchester and Liverpool are much closer
in travel time than services in South Wales; and there is a "complex
inter-meshing of medical and clinical links involving clinics,
staff and technology with English Centres". Thus, cross-border
funding issues, though not unique to North Wales, are particularly
significant there. The North Wales Health Authority raised three
concerns stemming from the current changes to the NHS funding
arrangements. First, it was concerned that the new Specialised
Health Services Commission for Wales could "potentially duplicate
a number of contractual arrangements for North Wales patients"
and "could blur the objective of seamless commissioning".
Secondly, the change from commissioning for a resident-based population
to commissioning for a practice-based population with the setting
up of Local Health Groups has meant that 7,000 people in North
Wales will have services purchased by English authorities. (Conversely,
North Wales will purchase for 6,600 English patients.) Thirdly,
they were concerned that the change from Extra-Contractual Referrals
to Out of Area Treatments would involve a loss of financial control,
and could result in the Authority continuing to fund out of area
services, even though they had been reprovided locally. The NHS
Confederation witnesses were confident that the Specialised Health
Services Commission would not duplicate contracts made by health
authorities, and would be involved only with very specialised
services.[21]
They agreed, however, that the change to practice-based populations
could disadvantage Welsh health authorities, and that the change
to Out of Area Treatments could mean a loss of financial control.[22]
In his evidence, the Secretary of State recognised the reliance
of North Wales on services in England and assured us that this
would be taken into account in the "stocktake" underway.[23]
We urge the National Assembly to examine these concerns closely
and to ensure that patients in North Wales do not lose out because
of their traditional dependence on services in England.
1 HC 261. Back
2
See Fifth Report, HC 608. Back
3
Evidence, pp 43-44; pp 53-55. Back
4
Evidence, p 44; Qq 2-8. Back
5
Evidence, p 56, paragraphs 19 and 20, and pp 57-61; Qq 126-129. Back
6
HC 261, Part 5. Back
7
Evidence, p 56, paragraph 23; Q 119. Back
8
Evidence, pp 43 and 45; Qq 22-31. Back
9
Qq 141-142. Back
10
Q 129. Back
11
Evidence, p 46; Qq 41-42. Back
12
Qq 136-140. See also Evidence, p 62. Back
13
Evidence, p 46; Qq 59-65. See too Qq 168-173. Back
14
Q 168. Back
15
See Q 171. Back
16
Evidence, pp 76-79. Back
17
Qq 155-160. Back
18
Evidence, p 46; Q 39. Back
19
Qq 161-167. Back
20
Evidence, pp 79-82. Back
21
Q 43. Back
22
Qq 45-46. Back
23
Qq 130-131. Back
|